Apimeds Pharmaceuticals US, Inc. (APUS)
NYSE American · Healthcare · Drug Manufacturers - Specialty & Generic
$4.59+42.55%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $6.9M
- 52-week range
- $1.51 – $59.70
- 52-week change
- −82.50%
- EPS (trailing)
- −$36.03
Fiscal year to Dec 2025
- Net income
- −$6.0M
- Diluted EPS
- −$0.55
- Free cash flow
- −$9.0M
From the company’s annual report on SEC EDGAR.
About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Headquarters: Matawan, United States · mindwavedao.com